222 related articles for article (PubMed ID: 37724217)
1. Hidradenitis Suppurativa: A Literature Review Comparing Current Therapeutic Modalities.
Rathod U; Prasad PN; Patel BM; Patel B; Patel C; Gandhi SK; Patel P
Cureus; 2023 Aug; 15(8):e43695. PubMed ID: 37724217
[TBL] [Abstract][Full Text] [Related]
2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
3. Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment.
Napolitano M; Megna M; Timoshchuk EA; Patruno C; Balato N; Fabbrocini G; Monfrecola G
Clin Cosmet Investig Dermatol; 2017; 10():105-115. PubMed ID: 28458570
[TBL] [Abstract][Full Text] [Related]
4. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
[TBL] [Abstract][Full Text] [Related]
5. Emerging drugs for the treatment of hidradenitis suppurativa.
Folkes AS; Hawatmeh FZ; Wong A; Kerdel FA
Expert Opin Emerg Drugs; 2020 Sep; 25(3):201-211. PubMed ID: 32667213
[TBL] [Abstract][Full Text] [Related]
6. Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape.
Krueger JG; Frew J; Jemec GBE; Kimball AB; Kirby B; Bechara FG; Navrazhina K; Prens E; Reich K; Cullen E; Wolk K
Br J Dermatol; 2024 Jan; 190(2):149-162. PubMed ID: 37715694
[TBL] [Abstract][Full Text] [Related]
7. New perspectives on the treatment of hidradenitis suppurativa.
Amat-Samaranch V; Agut-Busquet E; Vilarrasa E; Puig L
Ther Adv Chronic Dis; 2021; 12():20406223211055920. PubMed ID: 34840709
[TBL] [Abstract][Full Text] [Related]
8. New and Emerging Targeted Therapies for Hidradenitis Suppurativa.
Markota Čagalj A; Marinović B; Bukvić Mokos Z
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409118
[TBL] [Abstract][Full Text] [Related]
9. Use of biological treatments in patients with hidradenitis suppurativa.
Martin-Ezquerra G; Masferrer E; Pujol RM
G Ital Dermatol Venereol; 2017 Aug; 152(4):373-378. PubMed ID: 27982551
[TBL] [Abstract][Full Text] [Related]
10. Hidradenitis suppurativa in the pediatric population.
Liy-Wong C; Pope E; Lara-Corrales I
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613
[TBL] [Abstract][Full Text] [Related]
11. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.
Zouboulis CC; Bechara FG; Dickinson-Blok JL; Gulliver W; Horváth B; Hughes R; Kimball AB; Kirby B; Martorell A; Podda M; Prens EP; Ring HC; Tzellos T; van der Zee HH; van Straalen KR; Vossen ARJV; Jemec GBE
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):19-31. PubMed ID: 30176066
[TBL] [Abstract][Full Text] [Related]
12. Hidradenitis Suppurativa: Rapid Evidence Review.
Wipperman J; Bragg DA; Litzner B
Am Fam Physician; 2019 Nov; 100(9):562-569. PubMed ID: 31674740
[TBL] [Abstract][Full Text] [Related]
13. The Pathogenesis and Treatment of Hidradenitis Suppurativa.
Agnese ER; Tariche N; Sharma A; Gulati R
Cureus; 2023 Nov; 15(11):e49390. PubMed ID: 38146560
[TBL] [Abstract][Full Text] [Related]
14. Topical management and wound care approaches for hidradenitis suppurativa.
Antia C; Alavi A; Alikhan A
Semin Cutan Med Surg; 2017 Jun; 36(2):58-61. PubMed ID: 28538745
[TBL] [Abstract][Full Text] [Related]
15. Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials.
Jemec GBE; Okun MM; Forman SB; Gulliver WPF; Prens EP; Mrowietz U; Armstrong AW; Geng Z; Gu Y; Williams DA; Teixeira HD; Kimball AB
Br J Dermatol; 2019 Nov; 181(5):967-975. PubMed ID: 30916379
[TBL] [Abstract][Full Text] [Related]
16. New Insight into the Molecular Pathomechanism and Immunomodulatory Treatments of Hidradenitis Suppurativa.
Molinelli E; Gioacchini H; Sapigni C; Diotallevi F; Brisigotti V; Rizzetto G; Offidani A; Simonetti O
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176138
[TBL] [Abstract][Full Text] [Related]
17. Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa.
Fotiadou C; Vakirlis E; Ioannides D
Clin Cosmet Investig Dermatol; 2016; 9():367-372. PubMed ID: 27799806
[TBL] [Abstract][Full Text] [Related]
18. Interventions for hidradenitis suppurativa.
Ingram JR; Woo PN; Chua SL; Ormerod AD; Desai N; Kai AC; Hood K; Burton T; Kerdel F; Garner SE; Piguet V
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010081. PubMed ID: 26443004
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
Peterson GC; Preston A; Frieder J; Wang X; Paek SY
Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
[TBL] [Abstract][Full Text] [Related]
20. Hidradenitis Suppurativa: Advances in Diagnosis and Treatment.
Saunte DML; Jemec GBE
JAMA; 2017 Nov; 318(20):2019-2032. PubMed ID: 29183082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]